Home › Astrocytoma › Virginia
Astrocytoma clinical trials in Virginia
5 studies for Astrocytoma are looking for participants at sites in Virginia.
Cities in Virginia
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- VCU Massey Comprehensive Cancer Center, Richmond
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 3, 2026 · NCT07215910Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- VCU Massey Comprehensive Cancer Center, Richmond
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT06860594SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- UVA Health, Emily Couric Clinical Cancer Cente, Charlottesville
- Inova Schar Cancer Institute, Fairfax
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT05303519VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
- Inova Schar Cancer, Fairfax
RecruitingPhase 2
Ages 18 to 98 · All sexes · Updated Sep 21, 2026 · NCT07831369FearLess in NeuroOncology
- Virginia Commonwealth University, Richmond
Recruiting
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06989086From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.